This Research Topic aims to collect all the Case Reports submitted to the Multiple Sclerosis and Neuroimmunology section. All the Case Reports submitted to this collection will be personally assessed by the Specialty Chief Editor before the beginning of the peer-review process. Please make sure your article adheres to the following guidelines before submitting it.
Case Reports highlight unique cases of patients that present with an unexpected diagnosis, treatment outcome, or clinical course. Only Case Reports that are original and significantly advance the field will be considered.
Case Report format:
Maximum word count: 3,000
Maximum number of display items (figures, tables, or videos): 4.
- Title: Case Report: “area of focus”
- Abstract.
- Introduction: including what is unique about the case and medical literature references.
- Case description: including de-identified patient information, relevant physical examination and other clinical findings, relevant past interventions, and their outcomes.
- A figure or table showcasing a timeline with relevant data from the episode of care.
- Diagnostic assessment, details on the therapeutic intervention, follow-up, and outcomes, as specified in the CARE guidelines.
- Discussion: strengths and limitations of the approach to the case, discussion of the relevant medical literature (similar and contrasting cases), take-away lessons from the case.
- Patient perspective.
Please, note that authors are required to obtain written informed consent from the patients (or their legal representatives) for the publication.
Authors should follow the CARE guidelines (https://www.care-statement.org/) and submit a completed CARE checklist as a supplementary file (template available here: http://data.care-statement.org/wp-content/uploads/2019/03/CARE-checklist-English-2013.pdf)
IMPORTANT: Any Case Report submitted to the Multiple Sclerosis and Neuroimmunology section outside this collection might experience delays, as they will be sent for assessment to the Specialty Chief Editor prior to beginning the peer review.
This Research Topic aims to collect all the Case Reports submitted to the Multiple Sclerosis and Neuroimmunology section. All the Case Reports submitted to this collection will be personally assessed by the Specialty Chief Editor before the beginning of the peer-review process. Please make sure your article adheres to the following guidelines before submitting it.
Case Reports highlight unique cases of patients that present with an unexpected diagnosis, treatment outcome, or clinical course. Only Case Reports that are original and significantly advance the field will be considered.
Case Report format:
Maximum word count: 3,000
Maximum number of display items (figures, tables, or videos): 4.
- Title: Case Report: “area of focus”
- Abstract.
- Introduction: including what is unique about the case and medical literature references.
- Case description: including de-identified patient information, relevant physical examination and other clinical findings, relevant past interventions, and their outcomes.
- A figure or table showcasing a timeline with relevant data from the episode of care.
- Diagnostic assessment, details on the therapeutic intervention, follow-up, and outcomes, as specified in the CARE guidelines.
- Discussion: strengths and limitations of the approach to the case, discussion of the relevant medical literature (similar and contrasting cases), take-away lessons from the case.
- Patient perspective.
Please, note that authors are required to obtain written informed consent from the patients (or their legal representatives) for the publication.
Authors should follow the CARE guidelines (https://www.care-statement.org/) and submit a completed CARE checklist as a supplementary file (template available here: http://data.care-statement.org/wp-content/uploads/2019/03/CARE-checklist-English-2013.pdf)
IMPORTANT: Any Case Report submitted to the Multiple Sclerosis and Neuroimmunology section outside this collection might experience delays, as they will be sent for assessment to the Specialty Chief Editor prior to beginning the peer review.